Compound 1493
Identifiers
- Canonical SMILES:
OCc1cc(Cl)ccc1Cn1cnc(c1-c1c[nH]c2cc(Cl)c(F)cc12)-c1ccccc1
- InChi:
InChI=1S/C25H18Cl2FN3O/c26-18-7-6-16(17(8-18)13-32)12-31-14-30-24(15-4-2-1-3-5-15)25(31)20-11-29-23-10-21(27)22(28)9-19(20)23/h1-11,14,29,32H,12-13H2
- InChiKey:
CMMPINPDDWCROT-UHFFFAOYSA-N
External links
![]() 168317961 |
External search
![]() |
![]() |
![]() |
![]() |
![]() |
Bibliography (1)
Pharmacological data
Biochemical tests | Cellular tests | PK tests | Cytotoxicity tests |
---|---|---|---|
1 | 0 | 0 | 0 |
Targets
PPI family | Best activity | Diseases | MMoA |
---|---|---|---|
MDM2-Like / P53 | 6.96 | cancer | Inhibition |
Physicochemical filters
Descriptor | Lipinski's RO5 | Veber | Pfizer's 3/75 | |
---|---|---|---|---|
Compliance | ||||
MW | 465.08 g/mol | |||
HBA | 4 | |||
HBD | 2 | |||
HBA + HBD | 6 | |||
AlogP | 6.09 | |||
TPSA | 53.84 | |||
RB | 4 |
Radar chart
PCA : iPPI-DB chemical space
PCA : Correlation circle
Efficiencies: iPPI-DB biplot LE versus LLE
Summary
Bibliographic ressources | Biochemical tests | Cellular tests | PK tests | Cytotoxicity tests |
---|---|---|---|---|
1 | 1 | 0 | 0 | 0 |
Pharmacological data
Bibliography | Name | Target | Competition | Assay type | Assay name | Cell line | Activity type | Activity |
---|---|---|---|---|---|---|---|---|
WO2008119741 | 148 | MDM2 Q00987 |
|
Biochemical assay | Time-Resolved FRET | pIC50 (half maximal inhibitory concentration, -log10) | 6.96 |
Ta | Structure | Name | Drugbank ID |
---|---|---|---|
0.5963 | 4-(4-FLUOROPHENYL)-1-CYCLOROPROPYLMETHYL-5-(4-PYRIDYL)-IMIDAZOLE | DB08522 | |
0.5440 | 4-(Fluorophenyl)-1-Cyclopropylmethyl-5-(2-Amino-4-Pyrimidinyl)Imidazole | DB03980 | |
0.5160 | 4-[1-(2,6-dichlorobenzyl)-2-methyl-1H-imidazol-4-yl]pyrimidin-2-amine | DB08076 | |
0.5130 | SB220025 | DB04338 | |
0.5102 | Navoximod | DB15439 | |
0.4554 | Ralimetinib | DB11787 | |
0.4534 | Chlormidazole | DB13611 | |
0.4525 | 4-[4-(4-Fluorophenyl)-2-[4-[(R)-methylsulfinyl]phenyl]-1H-imidazol-5-yl]pyridine | DB08521 | |
0.4484 | Cyclopropyl-{4-[5-(3,4-Dichlorophenyl)-2-[(1-Methyl)-Piperidin]-4-Yl-3-Propyl-3h-Imidazol-4-Yl]-Pyrimidin-2-Yl}Amine | DB03084 | |
0.4444 | Cyclohexyl-{4-[5-(3,4-Dichlorophenyl)-2-Piperidin-4-Yl-3-Propyl-3h-Imidazol-4-Yl]-Pyrimidin-2-Yl}Amine | DB02388 | |
0.4416 | N-(2-hydroxy-1,1-dimethylethyl)-1-methyl-3-(1H-pyrrolo[2,3-b]pyridin-2-yl)-1H-indole-5-carboxamide | DB06834 | |
0.4384 | Telmisartan | DB00966 | |
0.4369 | Cimicoxib | DB05095 | |
0.4235 | 3,4-bis(7-chloro-1H-indol-3-yl)-1H-pyrrole-2,5-dicarboxylic acid | DB06955 | |
0.4198 | N-[4-(5-fluoro-6-methylpyridin-2-yl)-5-quinoxalin-6-yl-1H-imidazol-2-yl]acetamide | DB07152 |